Chronic Myeloproliferative Disorders  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
GLOBAL, NCT00354120 / 2005-000805-68: Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Completed
2/3
121
Europe
Alentuzumab, Globulina antilinfocitaria
Gruppo Italiano Trapianto di Midollo Osseo
Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Myelofibrosis, Lympho-proliferative Diseases
08/11
08/11

Download Options